FDA-approved Product

Therapy Areas

Educational Resources

Diabetes – Insulins

Associated Clinical Guidelines and Recommendations
American Diabetes Association Standards of Care in Diabetes – 2026

Insulin A to Z Slide Deck
A comprehensive presentation on pathophysiology and epidemiology of type 1 and 2 diabetes. This resource reviews the challenges, beliefs, and clinical inertia associated with insulin use, as well as the insulin formulations available in the U.S.

Atrial Fibrillation

Associated Clinical Guidelines and Recommendations
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
2024 European Society of Cardiology (ESC) Guidelines for the Management of Atrial Fibrillation

Osteoarthritis

AAOS Guidelines for Osteoarthritis of the Knee (2021)
This clinical practice guideline is intended for use with adults who have been diagnosed with osteoarthritis of the knee and are undergoing treatment.

Prostate Cancer

PCWG3 Guidelines (2015)
Prostate Cancer Working Group 3 (PCWG3) guidelines focus on the response criteria and assessment methods for prostate cancer clinical trials

Tumor Lysis Syndrome

Sanofi does not review or control the content of non-Sanofi websites.

Engage with Sanofi Payer Medical

Contact
Subscribe
Give feedback

Explore Other Therapy Areas

Immunology and Inflammation Resources


FDA-approved Product Therapy Areas
R&D Pipeline Therapy Areas

Neurology Resources


FDA-approved Product Therapy Areas
R&D Pipeline Therapy Areas

Oncology Resources


FDA-approved Product Therapy Areas
R&D Pipeline Therapy Areas

Rare Blood Disorders Resources


FDA-approved Product Therapy Areas
R&D Pipeline Therapy Areas

Member Engagement and Population Health Resources


Learn more

Rare Diseases


Learn more

Type 1 Diabetes


FDA-approved Product Therapy Areas

Chronic Graft-versus-Host Disease


FDA-approved Product Therapy Areas

MAT-US-2607372 v1.0 – P. Approved for Distribution. 07/2026